APA (7th ed.) Citation

PF, M., KW, E., A, A., K, C., X, Z., H, Z., . . . F, M. (2016). Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. PloS one, 11(3), e0151121. https://doi.org/10.1371/journal.pone.0151121

Chicago Style (17th ed.) Citation

PF, McAuliffe, et al. "Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes." PloS One 11, no. 3 (2016): e0151121. https://doi.org/10.1371/journal.pone.0151121.

MLA (9th ed.) Citation

PF, McAuliffe, et al. "Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes." PloS One, vol. 11, no. 3, 2016, p. e0151121, https://doi.org/10.1371/journal.pone.0151121.